In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares closed yesterday at $25.57. Pick the best stocks and ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Novo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.

In testing, duvakitug proved to be well tolerated with no new safety issues. Evercore ISI analyst Umer Raffat noted the placebo-adjusted responses to Teva's drug were better than the same for ...